In this regard, two groups have recently demonstrated that genetic ablation or pharmacological inhibition of IL-1β or IL-1 receptor 1 attenuates clonal expansion and bone marrow fibrosis and osteosclerosis in Jak2V617F MPN mouse models (60, 61). This evidence concerns the gene IL1B and primary myelofibrosis.